Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 168 Myelodysplastic Syndromes 160 Leukemia 156 Anemia 151 Leukemia, Myeloid, Acute 144 Neoplasms 124 Precursor Cell Lymphoblastic Leukemia-Lymphoma 115 Leukemia, Myelomonocytic, Chronic 111 Multiple Myeloma 90 Myeloproliferative Disorders 89 Leukemia, Lymphocytic, Chronic, B-Cell 87 Lymphoma, Non-Hodgkin 76 Hodgkin Disease 71 Lymphoma 66 Congenital Abnormalities 64 Anemia, Refractory 64 Venous Thromboembolism 63 Thrombocytopenia 59 Blast Crisis 57 Leukemia, Myeloid, Chronic-Phase 56 Leukemia, Myeloid, Accelerated Phase 52 Lymphoma, Follicular 51 Myelodysplastic-Myeloproliferative Diseases 48 Anemia, Aplastic 46 Primary Myelofibrosis 44 Lymphoma, Mantle-Cell 44 Neoplasms, Plasma Cell 43 Lymphoma, Large B-Cell, Diffuse 41 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 41 Burkitt Lymphoma 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Shock, Septic × Classical hematology × Clear all

NCT03837171 2024-06-25

TRANSPORT

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Classical hematology

Anemia, Neoplasms, Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡